Skip to main content

#151036

Anti-ICAM1 [15.2]

Cat. #151036

Anti-ICAM1 [15.2]

Cat. #: 151036

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: ICAM1 (CD54)

Class: Monoclonal

Application: FACS ; IHC ; IP ; Fn

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Nancy Hogg

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-ICAM1 [15.2]
  • Alternate name: Intercellular Adhesion Molecule 1; Major Group Rhinovirus Receptor; ICAM-1; Cell Surface Glycoprotein P3.58; Human Rhinovirus Receptor; P3.58; CD54; BB2
  • Research fields: Cell biology;Immunology;Stem cell biology;Tissue-specific biology
  • Clone: 15.2
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 85-115 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IHC ; IP ; Fn
  • Description: ICAMs are members of the immunoglobulin superfamily that is characterised by the presence of immunoglobulin-like domains. ICAM-1 is expressed in haemopoietic cells and vascular endothelium. Cytokine activation causes ICAM-1 expression in other cell types such as fibroblasts and keratinocytes. ICAM-1 is involved in leukocyte recruitment and inflammation. ICAM-1 binds LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18).
  • Immunogen: Rheumatoid synovial cells and human monocytes.
  • Isotype: IgG1
  • Myeloma used: Sp2/0-Ag14
  • Recommended controls: Tonsil

Target Details

  • Target: ICAM1 (CD54)
  • Molecular weight: 85-115 kDa
  • Tissue cell line specificity: Tonsil
  • Target background: ICAMs are members of the immunoglobulin superfamily that is characterised by the presence of immunoglobulin-like domains. ICAM-1 is expressed in haemopoietic cells and vascular endothelium. Cytokine activation causes ICAM-1 expression in other cell types such as fibroblasts and keratinocytes. ICAM-1 is involved in leukocyte recruitment and inflammation. ICAM-1 binds LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18).

Applications

  • Application: FACS ; IHC ; IP ; Fn

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -20° C
  • Shipping conditions: Dry ice

References

  • Vsquez et al. 2016. Microbes Infect. :. PMID: 27717894.
  • Plasmodium falciparum isolates from patients with uncomplicated malaria promote endothelial inflammation.
  • Intercellular adhesion molecule 1 serves as a primary cognate receptor for the Type IV pilus of nontypeable Haemophilus influenzae.
  • Novotny et al. 2016. Cell Microbiol. :. PMID: 26857242.
  • Perturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: implication in osteoarthritis pathogenesis.
  • El-Bikai et al. 2010. Arthritis Res Ther. 12(5):R201. PMID: 20977750.
  • Conway et al. 2010. Am J Physiol Heart Circ Physiol. 298(2):H367-74. PMID: 19915176.
  • Endothelial cell responses to atheroprone flow are driven by two separate flow components: low time-average shear stress and fluid flow reversal.
  • Lauriello et al. 2005. Acta Otorhinolaryngol Ital. 25(5):284-91. PMID: 16602327.
  • A two-year course of specific immunotherapy or of continuous antihistamine treatment reverse eosinophilic inflammation in severe persistent allergic rhinitis.
  • Stanley et al. 2000. Biochem J. 351(Pt 1):79-86. PMID: 10998349.
  • The second domain of intercellular adhesion molecule-1 (ICAM-1) maintains the structural integrity of the leucocyte function-associated antigen-1 (LFA-1) ligand-binding site in the first domain.
  • Dransfield et al. 1992. J Cell Biol. 116(6):1527-35. PMID: 1541641.
  • Interaction of leukocyte integrins with ligand is necessary but not sufficient for function.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.